The Longs and the Shorts of my trading on the JSE. My thoughts, actions and rambelings while trading. The thing I love best!
Friday, May 11, 2007
Barr Pharmaceuticals gets tentative OK for generic dementia drug
(Reuters) - The product had annual sales of about $140 million for the 12 months ended March 2007, according to IMS sales data. Janssen Pharmaceutica is a unit of Johnson & Johnson
No comments:
Post a Comment